PLEASE NOTE: This course is pending approval in the following states: Kentucky (CLE), Wisconsin (CLE). The application for CLE approval has been submitted to the respective state accrediting agency(s) and is awaiting final confirmation. Click here to learn more.
This program will provide an overview of federal regulation of the cannabis industry, in light of the Department of Justice’s recent rescission of the Cole Memorandum, a 2013 memo that symbolized a major shift in drug enforcement.
Presented by Jonathan Havens, Co-Chair of Saul Ewing Arnstein & Lehr’s Cannabis Law Practice, the program will also briefly explore the role of the Federal Drug Administration (FDA) and Drug Enforcement Administration (DEA) in cannabis regulation, and finally, will conclude with insights as to what’s in the store for the future of the cannabis industry.